| 000 | 015160000a22003370004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223030739.0 | ||
| 008 | 070111s2006 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.08.M.Sc.2006.Ha.B | ||
| 100 | 0 | _aHaidy Atef Abass Mostafa Ebid | |
| 245 | 1 | 2 |
_aA Biopharmaceutic Study on Citalopram Hydrobromide / _cHaidy Atef Abass Mostafa Ebid ; Supervised Ahmed Abd El bary , Nagwa Ali Sabri |
| 246 | 1 | 5 | _aدراسة بيوصيدلية على السيتالوبرام هايدروبروميد |
| 260 |
_aCairo : _bHaidy Atef Abass Mostafa Ebid , _c2006 |
||
| 300 |
_a213P : _bcharts ; _c30cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty Of Pharmacy - Department Of Pharmaceutics | ||
| 520 | _aBecause these drugs , which are as potent antidepressants as the tricyclics , are devoid of most of the secondary effects of the latter drugs (orthostatic hypotension , weight gain , dry mouth , etc , mainly caused by their capacity to block alpha1 - adrenergic , H1 histaminergic and muscarinic receptors) | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBiopharmaceutic Study | |
| 653 | 4 | _aCitalopram Hydrobromide | |
| 653 | 4 | _apotent antidepressants | |
| 700 | 0 |
_aAhmed Abd El bary , _eSupervisor |
|
| 700 | 0 |
_aNagwa Ali Sabri , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aAmira _eCataloger |
||
| 905 |
_aEsam _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c41099 _d41099 |
||